Centene Corp.
Can Centene keep lowering its medical cost ratio fast enough to offset work-requirement driven membership losses and a much smaller individual market?
Last 4 earnings calls · through Q2 FY2026
Bull case
Medicaid rate and cost alignment
The bull case is that Centene is bending Medicaid cost trend faster than rates rise, so its largest segment earns more on each premium dollar.
Marketplace repricing
Centene repriced its individual market plans to cover a sicker risk pool, turning a segment loss into a normal margin within one year.
Cash generation and debt paydown
Strong cash generation has moved the balance sheet from net debt to net cash, giving management room to keep funding margin work.
Bear case
Work requirements and tax credits
The bear case is that federal policy shrinks Centene's membership faster than the company can reprice, spreading fixed costs over fewer people.
Medicaid membership attrition
Medicaid enrollment is falling faster than planned, and the members leaving are the cheaper ones, which pushes the remaining pool's costs up.
Thin margins and one-time items
Health plan margins are thin enough that a small change in medical costs moves earnings a lot, and recent results lean on items that will not repeat.
Contract reprocurement and regulation
Medicaid contracts are rebid regularly and can be lost outright, and regulators can change the rules that set revenue and eligibility.
Bull and bear points
Growth & Execution
In short: Guidance has been raised twice, while Medicaid and Marketplace membership are both shrinking.
Medicaid rates came in above the April plan
The July rate cohort was stronger than forecast, lifting the full-year rate yield and narrowing the gap between premium revenue and medical cost.
Tone shiftQ1 FY2026 → Q2 FY2026Full-year earnings guidance was raised twice
Management lifted the 2026 outlook from more than $3 to more than $4.80 a share after two strong quarters, and has beaten estimates in seven of the last eight quarters.
Q2 FY2026 call
Medicaid membership is now falling faster
In February management expected a mid single-digit decline in member months; by July it guided to an 8% to 9% drop, which removes revenue and shifts the remaining risk pool.
Tone shiftQ4 FY2025 → Q2 FY2026Marketplace membership roughly halved in one year
Individual market enrollment fell from about five million in December to roughly three and a half million by March, and Centene expects further attrition as eligibility checks resume.
Q4 FY2025 call
Profitability & Financial Strength
In short: Cash flow and debt have improved sharply, while earnings still lean on one-time items and thin margins.
Marketplace margin outlook raised to 4.5% to 5%
After holding guidance near 3% in April while waiting for market data, management now expects the individual market to earn 4.5% to 5% this year, after losing money in 2025.
Tone shiftQ1 FY2026 → Q2 FY2026Medicaid medical cost ratio improved four quarters running
The Medicaid health benefits ratio fell from its mid-2025 peak as trend programs, network changes and state rate corrections took hold, and management still calls the result short of a normal margin.
Q4 FY2025 callFree cash flow reached $9.0 billion
Cash generated over the last twelve months was far above the prior year and equal to 4.4% of revenue, funding debt repayment and the cost programs behind margin recovery.
Filed financials
About $0.50 of quarterly earnings will not repeat
The second quarter included settlements of prior-year risk adjustment and quality items that management itself excludes from its 2027 baseline, so 2026 guidance overstates the run rate.
Q2 FY2026 callThin margins amplify small cost misses
Health plan margins are narrow enough that a modest rise in the medical cost ratio moves earnings sharply, and goodwill was written down heavily in 2025 after the outlook fell.
10-K, filed 2026-02-17
Market Position
In short: Scale in Medicaid and Part D is large, but federal policy and contract losses can shrink it.
Centene is the largest stand-alone Part D provider
Handling roughly $60 billion of pharmacy spend without owning a pharmacy benefit manager gives Centene direct leverage on drug costs across Medicaid, Medicare and the individual market.
Q4 FY2025 callState budget pressure strengthens the partnership
When states need savings they ask managed care for program changes and to move specialty populations into managed care, which can add members even when rates stay flat.
Q2 FY2026 call
Federal Medicaid rule changes cut eligibility and funding
Work requirements and lower federal matching funds under the 2025 budget law reach the expansion population from 2027, and management says that will mute margin recovery.
10-K, filed 2026-02-17Centene lost the Texas and Georgia Medicaid rebids
Both awards are under protest, and because Medicaid contracts run for fixed terms and are routinely rebid, losing a large state removes revenue abruptly and is costly to contest.
10-K, filed 2026-02-17